New and updated preclinical and clinical data presented by biopharma firms at the European Hematology Association's Annual Congress, including: ADC, Agios, Alx, Apellis, Aprea, Aptose, Astrazeneca, Autolus, Beigene, Bluebird, Constellation, Crispr, Editas, Forma, Imago, Imara, Geron, Keros, Kiadis, Omeros, Oryzon, Principia, Sierra Oncology, Takeda, TG, Tolero, Vertex, X4.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Adial, Biovie, Kite, Leap, Viela, ZZ.
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Agios, BMS, Celgene, Dcprime, Revive, Royalty, Scopus, Tonix, Trigemina.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Agios, Atox, Aura, Bone Therapeutics, Cytodyn, Lilly, Noveome, Novo, Octimet, Otsuka, Pulmocide, Respivant, Verrica.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Establishment Labs, Medtronic.